There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Since the introduction of highly active antiretroviral therapy (HAART), little is
known about whether changes in HIV-1 mortality and morbidity rates have been sustained.
We aimed to assess possible changes in these rates across Europe.
[1
]
Royal Free Centre for HIV Medicine and Department of Primary Care and Population Sciences,
Royal Free and University College Medical School, London, UK. a.mocroft@pcps.ucl.ac.uk